Focus Partners Wealth’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,879
| Closed | -$348K | – | 2042 |
|
|
2025
Q1 | $348K | Sell |
36,879
-452
| -1% | -$4.26K | ﹤0.01% | 1491 |
|
|
2024
Q4 | $460K | Buy |
37,331
+22
| +0.1% | +$271 | ﹤0.01% | 1356 |
|
|
2024
Q3 | $558K | Sell |
37,309
-3,418
| -8% | -$51.1K | ﹤0.01% | 1101 |
|
|
2024
Q2 | $550K | Sell |
40,727
-1,924
| -5% | -$26K | ﹤0.01% | 924 |
|
|
2024
Q1 | $709K | Buy |
42,651
+11,497
| +37% | +$191K | 0.01% | 660 |
|
|
2023
Q4 | $420K | Buy |
+31,154
| New | +$420K | 0.01% | 606 |
|